Prime Vendor Agreement Sample Contracts

Diplomat Pharmacy – Fifth Amendment to Prime Vendor Agreement (November 6th, 2017)

This Fifth Amendment (Fifth Amendment) is made and entered into as of August 3, 2017 (Fifth Amendment Effective Date), by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (Diplomat) for itself and on behalf of the following affiliated and commonly controlled companies of Diplomat: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft. Lauderdale, LLC, Diplomat Specialty Pharmacy Great Lakes Distribution Center, LLC, Diplomat Specialty Pharmacy of Southern California, LLC, Navigator Pharmacy Service, LLC, Diplomat Specialty Pharmacy of Philadelphia, LLC, Diplomat Specialty Pharmacy of Boothwyn, LLC, BioRx, LLC, Valley Campus Pharmacy, Inc. d/b/a TNH Specialty Pharmacy, Affinity Biotech, Inc., At-Home IV Infusion Professional Inc., XAS Infusion Suites Inc., American Homecare

Diplomat Pharmacy – Fourth Amendment to Prime Vendor Agreement (November 6th, 2017)

This Fourth Amendment (Fourth Amendment) is made and entered into as of May 8, 2017 (Fourth Amendment Effective Date), by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (Diplomat) for itself and on behalf of the following limited liability companies of which Diplomat is the sole member: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft. Lauderdale, LLC, Diplomat Specialty Pharmacy Great Lakes Distribution Center, LLC, Diplomat Specialty Pharmacy of Southern California, LLC, Navigator Pharmacy Service, LLC, Diplomat Specialty Pharmacy of Philadelphia, LLC, Diplomat Specialty Pharmacy of Boothwyn, LLC, BioRx, LLC and Valley Campus Pharmacy, Inc. d/b/a TNH Specialty Pharmacy (Diplomat and such limited liability companies being referred to herein collectively as Customer

Ascendant Solutions – Prime Vendor Agreement (July 21st, 2017)

This Prime Vendor Agreement (the "Agreement") is made by and between Cardinal Health 110, LLC and Cardinal Health 411, Inc. ("Cardinal Health") and Dougherty's Holdings, Inc. ("Buyer"), who hereby agree as follows:

Ascendant Solutions – To the Prime Vendor Agreement (June 2nd, 2017)

This Third Amendment to the Prime Vendor Agreement (the "Third Amendment") is made and entered into by and between Dougherty's Holdings, Inc. ("Buyer") and Cardinal Health 110, LLC, Cardinal Health 411, Inc. and Cardinal Health 112, LLC (collectively referred to herein as "Cardinal Health").

Ascendant Solutions – To the Prime Vendor Agreement (June 2nd, 2017)

This First Amendment to the Prime Vendor Agreement (the "First Amendment") is made and entered into by and between Dougherty's Holdings, Inc. ("Buyer") and Cardinal Health 110, LLC (f/k/a Cardinal Health 110, Inc.) and Cardinal Health 411, Inc. (collectively referred to herein as "Cardinal Health").

Ascendant Solutions – To the Prime Vendor Agreement (June 2nd, 2017)

This Second Amendment to the Prime Vendor Agreement (the "Second Amendment") is made and entered into by and between Dougherty's Holdings, Inc. ("Buyer") and Cardinal Health 110, LLC and Cardinal Health 411, Inc. (collectively referred to herein as "Cardinal Health").

Ascendant Solutions – To the Prime Vendor Agreement (June 2nd, 2017)

This Fifth Amendment to the Prime Vendor Agreement (the "Fifth Amendment") is made and entered into by and between Dougherty's Holdings, Inc. ("Buyer") and Cardinal Health 110, LLC and Cardinal Health 112, LLC (collectively referred to herein as "Cardinal Health").

Ascendant Solutions – To the Prime Vendor Agreement (June 2nd, 2017)

This Sixth Amendment to the Prime Vendor Agreement (the "Sixth Amendment") is made and entered into by and between Dougherty's Holdings, Inc. ("Buyer") and Cardinal Health 110, LLC and Cardinal Health 112, LLC (collectively referred to herein as "Cardinal Health").

Ascendant Solutions – To the Prime Vendor Agreement (June 2nd, 2017)

This Fourth Amendment to the Prime Vendor Agreement (the "Fourth Amendment") is made and entered into by and between Dougherty's Holdings, Inc. ("Buyer") and Cardinal Health 110, LLC and Cardinal Health 112, LLC (collectively referred to herein as "Cardinal Health").

Ascendant Solutions – Prime Vendor Agreement (June 2nd, 2017)

This Prime Vendor Agreement (the "Agreement") is made by and between Cardinal Health 110, LLC and Cardinal Health 411, Inc. ("Cardinal Health") and Dougherty's Holdings, Inc. ("Buyer"), who hereby agree as follows:

Tabula Rasa HealthCare, Inc. – Amended and Restated Prime Vendor Agreement (July 21st, 2016)

This Prime Vendor Agreement (PVA) is dated May 1, 2016 (Effective Date) between AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), and CareKinesis, Inc., a Delaware corporation, and J.A. Robertson, Inc., a California corporation d/b/a St. Mary (collectively, Customer).

Prime Vendor Agreement (May 7th, 2015)

This Prime Vendor Agreement (the "Agreement") is effective April 1, 2015 (the "Effective Date") between PharMerica Corporation located at 1901 Campus Place, Louisville, Kentucky 40299 ("you", "your" or "Customer") and Cardinal Health 110, LLC and Cardinal Health 411, Inc., 7000 Cardinal Place, Dublin Ohio 43017 (collectively, "we", "us" or "our" or "Cardinal Health"), who agree as follows:

Pharmaceutical Prime Vendor Agreement (February 25th, 2015)

THIS PHARMACEUTICAL PRIME VENDOR AGREEMENT ("Agreement") is made and entered into as of the 1st day of January, 2015 (the "Effective Date") by and between Omnicare, Inc. ("Omnicare"), a Delaware corporation with its principal place of business at 900 Omnicare Center, 201 E. Fourth Street, Cincinnati, Ohio 45202, and McKesson Corporation ("Vendor"), a Delaware corporation with its principal place of business at One Post Street, San Francisco, California 94104. Omnicare and Vendor are sometimes herein referred to individually as a "Party," and collectively and the "Parties."

Prime Vendor Agreement (September 11th, 2014)

This Prime Vendor Agreement (the "Agreement") is made by and between Cardinal Health 110, LLC and Cardinal Health 411, Inc. ("Cardinal Health") and Fred's Stores of Tennessee, Inc. ("Buyer") who hereby agree as follows:

Diplomat Pharmacy – First Amendment to Prime Vendor Agreement (August 19th, 2014)

This First Amendment (Amendment) is entered into as of July 20, 2012 (Effective Date) by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (Diplomat) for itself and on behalf of the following limited liability companies of which Diplomat is the sole member: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Grand Rapids, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft, Lauderdale, LLC, Diplomat Specialty Pharmacy of Swartz Creek, LLC and Diplomat Specialty Pharmacy of Southern California, LLC (Diplomat and such limited liability companies being referred to herein collectively as Customer) on the other hand. This Amendment amends the parties Prime Vendor Agreement dated January 1, 2012 (PVA). Capitalized terms not defined in this Amendment have the meaning set forth in the PVA.

Diplomat Pharmacy – Prime Vendor Agreement (August 19th, 2014)

This Prime Vendor Agreement (Agreement) is made as of January 1, 2012 (Effective Date) by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (Diplomat) for itself and on behalf of the following limited liability companies of which Diplomat is the sole member: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Grand Rapids, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft. Lauderdale, LLC, Diplomat Specialty Pharmacy of Swartz Creek, LLC and Diplomat Specialty Pharmacy of Southern California, LLC (Diplomat and such limited liability companies being referred to herein collectively as Customer) on the other hand.

First Amendment to the Amended and Restated Prime Vendor Agreement for Long- Term Care Pharmacies (May 1st, 2013)

This First Amendment (First Amendment) is entered into as of January 1, 2013 (the Effective Date), between AmerisourceBergen Drug Corporation (ABDC), on the one hand, and PharMerica Corporation (PMC), Pharmacy Corporation of America (PCA), and Chem Rx Pharmacy Services, LLC, (Chem Rx), on the other. (Collectively, PMC, PCA and Chem Rx are referred to hereafter as Customer) and amends the parties Amended and Restated Prime Vendor Agreement for Long-Term Care Pharmacies (Agreement) dated January 1, 2011.

Fifth Amendment to Prime Vendor Agreement (January 26th, 2012)

FIFTH AMENDMENT, dated as of January 1, 2012 ("Fifth Amendment") to the PRIME VENDOR AGREEMENT made as of July 1, 2009, as amended as of March 2010, June 1, 2010, August 1, 2010 and May 1, 2011 (the "Existing PVA"), between AmerisourceBergen Drug Corporation ("ABDC"), on the one hand, and Bioscrip, Inc., BioScrip Infusion Services, Inc., Chonimed LLC, Bioscrip Pharmacy Inc., Bradhurst Specialty Pharmacy, Inc., Bioscrip Pharmacy (NY), Inc., Bioscrip PBM Services, LLC, Natural Living Inc., Bioscrip Infusion Services, LLC, Bioscrip Nursing Services, LLC, Bioscrip Infusion Management, LLC, Bioscrip Pharmacy Services, Inc., Critical Homecare Solutions, Inc., Specialty Pharma, Inc, New England Home Therapies, Inc., Deaconess Enterprises, LLC, Infusion Solutions, Inc, Professional Home Care Services, Inc., Wilcox Medical, Inc., Deaconess Homecare, LLC, South Mississippi Home Health, Inc., Regional Ambulatory Diagnostics, Inc., Elk Valley Professional Affiliates, Inc., Infusion Partners, LLC,

Amended and Restated Prime Vendor Agreement for Long-Term Care Pharmacies (May 25th, 2011)

This Amended and Restated Prime Vendor Agreement for Long-Term Care Pharmacies (Agreement) is made as of January 1, 2011 (Effective Date) by and between AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), on the one hand, and PharMerica Corporation (PMC), a Delaware corporation; Pharmacy Corporation of America (PCA), a Delaware corporation; and Chem Rx Pharmacy Services, LLC, a Delaware limited liability company (Chem Rx), on the other. (Collectively, PMC, PCA and Chem Rx are sometimes referred to hereafter as Customer.)

Contract (May 2nd, 2011)

Note: Certain material has been omitted from this Fourth Amendment to Prime Vendor Agreement in accordance with a request for confidential treatment submitted to the Securities and Exchange Commission. [*****] indicates omitted material. The omitted material has been filed separately with the Securities and Exchange Commission.

Contract (May 2nd, 2011)

Note: Certain material has been omitted from this Third Amendment to Prime Vendor Agreement in accordance with a request for confidential treatment submitted to the Securities and Exchange Commission. [*****] indicates omitted material. The omitted material has been filed separately with the Securities and Exchange Commission.

Amended and Restated Prime Vendor Agreement for Long-Term Care Pharmacies (February 24th, 2011)

This Amended and Restated Prime Vendor Agreement for Long-Term Care Pharmacies (Agreement) is made as of January 1, 2011 (Effective Date) by and between AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), on the one hand, and PharMerica Corporation (PMC), a Delaware corporation; Pharmacy Corporation of America (PCA), a Delaware corporation; and Chem Rx Pharmacy Services, LLC, a Delaware limited liability company (Chem Rx), on the other. (Collectively, PMC, PCA and Chem Rx are sometimes referred to hereafter as Customer.)

Portions of This Exhibit Have Been Omitted Pursuant to a Request for Confidential Treatment and Filed Separately With the Securities and Exchange Commission. The Symbol "[***]" in This Exhibit Indicates That Information Has Been So Omitted. Prime Vendor Agreement for Pharmaceuticals (October 28th, 2010)

THIS AGREEMENT effective as of July 27, 2010 (the "Effective Date"), is between McKesson Corporation ("McKesson" or "MHS"), a Delaware corporation with its principal place of business at One Post Street, San Francisco, California 94104, and Omnicare, Inc. ("Omnicare"), a Delaware corporation with its principal place of business at 1600 RiverCenter 100 East RiverCenter Blvd. Covington, Kentucky 41011.

Prime Vendor Agreement (December 2nd, 2009)

This Prime Vendor Agreement ("Agreement") is made as of July 1, 2009 ("Agreement Date") by AmerisourceBergen Drug Corporation, a Delaware corporation ("ABDC"), and BioScrip, Inc., a Delaware corporation, on behalf of itself and its subsidiaries (collectively, "Customer").

Prime Vendor Agreement (November 2nd, 2009)

This Prime Vendor Agreement ("Agreement") is made as of July 1, 2009 ("Agreement Date") by AmerisourceBergen Drug Corporation, a Delaware corporation ("ABDC"), and BioScrip, Inc., a Delaware corporation, on behalf of itself and its subsidiaries (collectively, "Customer").

Prime Vendor Agreement (October 9th, 2008)

This Prime Vendor Agreement ("Agreement") is made as of July 1, 2008 ("Effective Date") by AmerisourceBergen Drug Corporation, a Delaware corporation ("ABDC"), and Assured Pharmacy, Inc., a Nevada corporation ("Customer").

Prime Vendor Agreement for Long-Term Care Pharmacies (November 9th, 2007)

This Prime Vendor Agreement for Long-Term Care Pharmacies (Agreement) is made as of August 1, 2007 (Effective Date) by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), and PharMerica Corporation, a Delaware corporation, on behalf of itself and its wholly owned subsidiaries (Customer).

Paramount Acquisition – Prime Vendor Agreement (November 1st, 2007)

This Prime Vendor Agreement (Agreement) is made as of April 1, 2007 (Effective Date) by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), and BJK, Inc., d.b.a. Chem Rx, a New York corporation (Customer).

Paramount Acquisition – Amendment to Prime Vendor Agreement (November 1st, 2007)

This is the first amendment (the Amendment) to the Prime Vendor Agreement (Agreement), dated May 1, 2007 (Agreement Date), among AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), and BJK, Inc., d.b.a. Chem Rx, a New York corporation (Customer), Chem Rx New Jersey, LLC, A New Jersey corporation and ChemRx/Salernos, LLC, a Pennsylvania limited liability company (Affiliates). This Amendment is effective as of October 26, 2007 (Effective Date).

Prime Vendor Agreement for Long-Term Care Pharmacies (July 13th, 2007)

This Prime Vendor Agreement for Long-Term Care Pharmacies (Agreement) is made as of [ ], 200[ ] (Effective Date) by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), and [ ], a Delaware corporation, on behalf of itself and its wholly owned subsidiaries (Customer).

Prime Vendor Agreement for Long-Term Care Pharmacies (May 24th, 2007)

This Prime Vendor Agreement for Long-Term Care Pharmacies (Agreement) is made as of [ ], 200[ ] (Effective Date) by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), and [ ], a Delaware corporation, on behalf of itself and its wholly owned subsidiaries (Customer).

Prime Vendor Agreement for Long-Term Care Pharmacies (March 26th, 2007)

This Prime Vendor Agreement for Long-Term Care Pharmacies (Agreement) is made as of [ ], 200[ ] (Effective Date) by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), and [ ], a Delaware corporation, on behalf of itself and its wholly owned subsidiaries (Customer).

National Medical Health Card Systems, Inc. – Prime Vendor Agreement (September 13th, 2006)

This Prime Vendor Agreement (Agreement) is made as of May 1, 2006 (Effective Date) by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), and NMHCRx Mail Order, Inc., dba NMHC Mail, a Delaware corporation (Customer).

FIRST AMENDMENT TO 2006 PRIME VENDOR AGREEMENT (Non-Rx Transition) (June 1st, 2006)

This is the first amendment (Amendment) to the 2006 Prime Vendor Agreement (2006 Agreement) dated March 14, 2006 (Agreement Effective Date) between AmerisourceBergen Drug Corporation (ABDC) and Longs Drug Stores California, Inc. (Longs). This Amendment is effective as of April 19, 2006 (Amendment Effective Date).

PRIME VENDOR AGREEMENT by and Between AmerisourceBergen Drug Corporation, a Delaware Corporation and Longs Drug Stores California, Inc., a California Corporation (June 1st, 2006)

This Prime Vendor Agreement (Agreement) is made as of March 14, 2006 (Execution Date) by AmerisourceBergen Drug Corporation, a Delaware corporation (ABDC), and Longs Drug Stores California, Inc., a California corporation (Longs).